Cell Therapy Process Development Support

Building scalable processes that perform reliably from bench to manufacturing

We design, optimize, and refine upstream and downstream processes to ensure they are robust, reproducible, and ready for scale‑up or tech transfer. Our approach blends practical cell‑culture and bioprocess experience with structured experimental design, giving you processes that withstand real‑world manufacturing pressures.

Upstream Process Development

  • Early upstream decisions; media, seeding density, feeding strategy, and culture conditions, directly impact yield, quality, and long‑term manufacturability. Thoughtful development prevents bottlenecks during scale‑up and reduces variability across operators and sites.

    • Expansion and differentiation strategy for 2D cultures, including detailed scale‑up and scale‑out planning.

    • Medium optimization to improve growth, productivity, and consistency.

    • Seeding and feeding strategy development to stabilize performance across batches.

    • In‑process control definition to monitor critical parameters and reduce failure modes.

    • Higher and more consistent yields across development stages.

    • Reduced variability during scale‑up and tech transfer.

    • Clear operating ranges and controls for regulatory documentation.

    • Strong scientific justification for upstream decisions.

    • Scale‑up / scale‑out plan detailing expansion strategy, culture format, and operational ranges.

    • Medium optimization report summarizing screening data, selected formulations, and rationale.

    • Seeding and feeding strategy documentation including setpoints, timing, and critical parameters.

    • In‑process control matrix defining monitoring requirements, acceptable ranges, and corrective actions.

    • Upstream development summary deck for governance meetings or internal technical reviews.

Downstream Process Development

  • Downstream steps—harvesting, formulation, freezing, and vialing, determine product stability, potency, and comparability. Well‑designed downstream processes reduce losses, prevent degradation, and ensure product quality through storage and distribution.

    • Harvesting optimization to maximize recovery and maintain product integrity.

    • Automated vialing strategy to improve consistency and reduce operator‑driven variability.

    • Formulation development to enhance stability and performance.

    • Freezing and storage condition optimization to protect product quality over time.

    • Improved product stability and potency.

    • Reduced batch failures and deviations.

    • Downstream workflows ready for tech transfer and scale‑up.

    • Documentation aligned with regulatory expectations for DS/DP handling.

    • Harvesting optimization report with yield analysis, recovery efficiency, and recommended workflow.

    • Automated vialing configuration and SOP‑ready workflow to support consistent execution.

    • Formulation development package including stability data, excipient justification, and final formulation selection.

    • Freezing and storage condition report outlining freeze profiles, hold times, and long‑term stability considerations.

    • Downstream process map showing stepwise operations, controls, and equipment requirements.

Process Characterization

  • haracterization provides the data needed to understand how your process behaves, what parameters matter, and how changes impact product quality. It is essential for comparability, regulatory submissions, and long‑term manufacturing control.

    • Quality attribute evaluation to define critical quality attributes (CQAs).

    • Potency and functional characterization to confirm biological activity.

    • Comparability studies to support process changes or scale transitions.

    • Identity and safety assessments to ensure product consistency.

    • Residuals and impurity profiling to meet regulatory expectations.

    • Stability studies to define storage conditions and shelf‑life.

    • Clear understanding of process performance and risks.

    • Defensible data packages for regulatory submissions.

    • Confident decision‑making during process changes or scale‑up.

    • Strong foundation for validation and long‑term control strategies.

    • CQA definition and justification aligned with product modality and regulatory expectations.

    • Potency and functional characterization data package with statistical analysis and acceptance criteria.

    • Comparability study report supporting process changes, scale transitions, or manufacturing site moves.

    • Identity, safety, and residuals assessment including impurity profiling and method references.

    • Stability study summary with trending, degradation pathways, and recommended shelf‑life strategy.